The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
114447855 11444785 5 F 20151108 20160706 20150902 20160708 PER PHEH2015US000977 NOVARTIS 2.37 YR M Y 0.00000 20160708 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
114447855 11444785 1 PS AFINITOR EVEROLIMUS 1 Oral 3 MG, QD 22334 3 MG TABLET QD
114447855 11444785 2 SS AFINITOR EVEROLIMUS 1 Oral 2 TO 3 MG, UNK 22334 TABLET
114447855 11444785 3 SS AFINITOR EVEROLIMUS 1 Oral 2 MG, UNK 22334 2 MG TABLET
114447855 11444785 4 SS AFINITOR EVEROLIMUS 1 Oral 3 MG, UNK 22334 3 MG TABLET
114447855 11444785 5 SS AFINITOR EVEROLIMUS 1 Oral 4 MG, UNK 22334 4 MG TABLET
114447855 11444785 6 SS AFINITOR EVEROLIMUS 1 Oral 2 TO 3 MG AND OCCASIONALLY 4 MG 22334 4 MG TABLET
114447855 11444785 7 SS AFINITOR EVEROLIMUS 1 Oral 2 TO 3 MG, UNK 22334 3 MG TABLET
114447855 11444785 8 SS AFINITOR EVEROLIMUS 1 Oral 3 MG, QD 22334 3 MG TABLET QD
114447855 11444785 9 SS AFINITOR EVEROLIMUS 1 Oral 4 MG, DAILY 22334 4 MG TABLET QD
114447855 11444785 10 SS AFINITOR EVEROLIMUS 1 Oral 7.5 MG, UNK 22334 7.5 MG TABLET QD
114447855 11444785 11 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 22334 10 MG TABLET QD
114447855 11444785 12 C VIGABATRINE VIGABATRIN 1 Unknown U 0
114447855 11444785 13 C TAURINE TAURINE 1 Unknown U 0
114447855 11444785 14 C SABRIL VIGABATRIN 1 Unknown U 0
114447855 11444785 15 C VITAMIN D CHOLECALCIFEROL 1 Unknown U 0
114447855 11444785 16 C RAPAMYCIN SIROLIMUS 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
114447855 11444785 1 Ganglioglioma
114447855 11444785 12 Seizure
114447855 11444785 13 Product used for unknown indication
114447855 11444785 14 Seizure
114447855 11444785 15 Product used for unknown indication
114447855 11444785 16 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
114447855 11444785 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
114447855 11444785 Blood cholesterol increased
114447855 11444785 Hand-foot-and-mouth disease
114447855 11444785 Malaise
114447855 11444785 Mouth swelling
114447855 11444785 Nasopharyngitis
114447855 11444785 Oral pain
114447855 11444785 Pyrexia
114447855 11444785 Rash
114447855 11444785 Respiratory tract infection
114447855 11444785 Seizure
114447855 11444785 Staphylococcal infection
114447855 11444785 Stomatitis
114447855 11444785 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
114447855 11444785 1 20141222 0
114447855 11444785 4 20150204 0
114447855 11444785 5 201501 0
114447855 11444785 11 20160622 20160702 0